The Biden Administration recently designated the fentanyl-xylazine combination as an emerging national threat. Aegis Sciences Corporation in Nashville has been...
NASHVILLE, Tenn., March 6, 2023 – Regina Sweeney, Vice President of Client Relations, Aegis Sciences Corporation has been presented with a Bronze...
Aegis recent panelist, Alex J. Krotulski, PhD, released an op-ed that is an exploration into the identification of new and...
CLEVELAND, Ohio, February 7, 2023 – Quadax, Inc., a leading provider of healthcare revenue cycle management technology and services commenced a...
Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he touches on Nashville's Drug Landscape, the...
The Centers for Disease Control publishes two Morbidity and Mortality Weekly Reports utilizing spike-protein target failure/performance, SGTF/rSGTP, as a proxy...
Sign up for the Aegis Newsletter